Kaufman Rossin Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$322K Buy
265
+32
+14% +$32.7K 0.15% 73
2026
Q1
$214K Buy
233
+41
+21% +$41.6K 0.12% 93
2025
Q4
$206K Buy
+192
New +$184K 0.11% 152
2025
Q2
Sell
-293
Closed -$242K 173
2025
Q1
$242K Buy
+293
New +$244K 0.17% 115

Other funds holding LLY

Kaufman Rossin Wealth's LLY Position: Q2 2026 in Review

Kaufman Rossin Wealth increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $32.7K and bringing the position to 265 shares worth $322K. The position accounts for 0.15% of the portfolio, ranked #73.

Kaufman Rossin Wealth first reported a position in LLY in Q1 2025 and has held it in 4 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kaufman Rossin Wealth held 265 shares of Eli Lilly worth $322K as of Q2 2026.
  • Kaufman Rossin Wealth bought 32 Eli Lilly shares in Q2 2026, an estimated $32.7K.
  • Eli Lilly made up 0.15% of Kaufman Rossin Wealth's portfolio in Q2 2026, its #73 holding.
  • Kaufman Rossin Wealth first reported a position in Eli Lilly in Q1 2025 and has held it in 4 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kaufman Rossin Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.